These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Extra-Large Gα Protein (XLαs) Deficiency Causes Severe Adenine-Induced Renal Injury with Massive FGF23 Elevation. Matthias J; Cui Q; Shumate LT; Plagge A; He Q; Bastepe M Endocrinology; 2020 Jan; 161(1):. PubMed ID: 31758181 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 23 and acute kidney injury. Neyra JA; Moe OW; Hu MC Pediatr Nephrol; 2015 Nov; 30(11):1909-18. PubMed ID: 25480729 [TBL] [Abstract][Full Text] [Related]
5. Regulation of FGF23 production and phosphate metabolism by bone-kidney interactions. Agoro R; White KE Nat Rev Nephrol; 2023 Mar; 19(3):185-193. PubMed ID: 36624273 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Durlacher-Betzer K; Hassan A; Levi R; Axelrod J; Silver J; Naveh-Many T Kidney Int; 2018 Aug; 94(2):315-325. PubMed ID: 29861060 [TBL] [Abstract][Full Text] [Related]
8. Research progress of fibroblast growth factor 23 in acute kidney injury. Zhang L; Qin W Pediatr Nephrol; 2023 Jul; 38(7):2013-2022. PubMed ID: 36416954 [TBL] [Abstract][Full Text] [Related]
9. Kidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis. Zhou W; Simic P; Zhou IY; Caravan P; Vela Parada X; Wen D; Washington OL; Shvedova M; Pierce KA; Clish CB; Mannstadt M; Kobayashi T; Wein MN; Jüppner H; Rhee EP J Clin Invest; 2023 Apr; 133(8):. PubMed ID: 36821389 [TBL] [Abstract][Full Text] [Related]
10. Orphan nuclear receptor ERR-γ regulates hepatic FGF23 production in acute kidney injury. Radhakrishnan K; Kim YH; Jung YS; Kim DK; Na SY; Lim D; Kim DH; Kim J; Kim HS; Choy HE; Cho SJ; Lee IK; Ayvaz Ş; Nittka S; Fliser D; Schunk SJ; Speer T; Dooley S; Lee CH; Choi HS Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33853949 [TBL] [Abstract][Full Text] [Related]
11. Kidney to bone via bedside to bench…and back? Grabner A; Wolf M J Clin Invest; 2020 Mar; 130(3):1106-1108. PubMed ID: 32065594 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease. Stubbs JR; He N; Idiculla A; Gillihan R; Liu S; David V; Hong Y; Quarles LD J Bone Miner Res; 2012 Jan; 27(1):38-46. PubMed ID: 22031097 [TBL] [Abstract][Full Text] [Related]
13. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease. Spichtig D; Zhang H; Mohebbi N; Pavik I; Petzold K; Stange G; Saleh L; Edenhofer I; Segerer S; Biber J; Jaeger P; Serra AL; Wagner CA Kidney Int; 2014 Jun; 85(6):1340-50. PubMed ID: 24402093 [TBL] [Abstract][Full Text] [Related]
18. Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease. Zhang S; Gillihan R; He N; Fields T; Liu S; Green T; Stubbs JR Kidney Int; 2013 Oct; 84(4):713-21. PubMed ID: 23698235 [TBL] [Abstract][Full Text] [Related]
19. A Control Region Near the Fibroblast Growth Factor 23 Gene Mediates Response to Phosphate, 1,25(OH)2D3, and LPS In Vivo. Lee SM; Carlson AH; Onal M; Benkusky NA; Meyer MB; Pike JW Endocrinology; 2019 Dec; 160(12):2877-2891. PubMed ID: 31599948 [TBL] [Abstract][Full Text] [Related]
20. Klotho expression in long bones regulates FGF23 production during renal failure. Kaludjerovic J; Komaba H; Sato T; Erben RG; Baron R; Olauson H; Larsson TE; Lanske B FASEB J; 2017 May; 31(5):2050-2064. PubMed ID: 28183805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]